The table below shows HAEMONETICS CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q2 2025
Q2 2024
Q2 2023
Q2 2022
Q2 2021
Q2 2020
Operating cash flow
$17.39M
-$27.42M
$19.09M
$41.99M
-$1.68M
$11.81M
Capital expenditure
$3.75M
$5.66M
$7.68M
$45.47M
$13.92M
$7.70M
Investing cash flow
-$33.00M
-$139.20M
-$15.26M
-$58.21M
-$15.85M
-$23.90M
Dividends paid
-
-
-
-
HAE operating cash flow (10-K history)
HAEMONETICS CORP reported operating cash flow of $293.22M for fiscal year 2026. That is up 61.4% from $181.72M in fiscal 2025. Over the 10 fiscal years shown, operating cash flow grew from $159.74M (FY 2017) to $293.22M. Figures come from the company's audited annual reports as filed with the SEC.
